Drug intelligence / Profile preview

StellaLife

Development stage: Phase 4
Lead developer: StellaLife
Administration: Topical

Overview

StellaLife is a biotech company that develops homeopathic oral care products, most notably the VEGA Oral Care line. These products are designed to accelerate healing, reduce pain, and decrease swelling following dental procedures such as extractions, implant placements, and periodontal surgery. The formulation typically includes a proprietary blend of homeopathic ingredients, including *Arnica montana*, *Calendula officinalis*, and *Hypericum perforatum*, which are intended to provide anti-inflammatory and analgesic effects. StellaLife products are often used as a natural alternative to opioids and steroids in dental recovery protocols and are integrated into opioid-free recovery programs in dentistry.

Brand names: StellaLifeVEGA Oral Care
Other names: StellaLife VEGA

Beyond the preview

Go deeper on StellaLife.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StellaLife.

Explore the full profile